1. Home
  2. RLAY vs TMP Comparison

RLAY vs TMP Comparison

Compare RLAY & TMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • TMP
  • Stock Information
  • Founded
  • RLAY 2015
  • TMP 1836
  • Country
  • RLAY United States
  • TMP United States
  • Employees
  • RLAY N/A
  • TMP N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • TMP Major Banks
  • Sector
  • RLAY Health Care
  • TMP Finance
  • Exchange
  • RLAY Nasdaq
  • TMP Nasdaq
  • Market Cap
  • RLAY 1.1B
  • TMP 892.4M
  • IPO Year
  • RLAY 2020
  • TMP N/A
  • Fundamental
  • Price
  • RLAY $5.11
  • TMP $75.40
  • Analyst Decision
  • RLAY Strong Buy
  • TMP Buy
  • Analyst Count
  • RLAY 9
  • TMP 1
  • Target Price
  • RLAY $20.88
  • TMP $68.00
  • AVG Volume (30 Days)
  • RLAY 1.3M
  • TMP 61.7K
  • Earning Date
  • RLAY 11-06-2024
  • TMP 10-25-2024
  • Dividend Yield
  • RLAY N/A
  • TMP 3.29%
  • EPS Growth
  • RLAY N/A
  • TMP 376.41
  • EPS
  • RLAY N/A
  • TMP 4.64
  • Revenue
  • RLAY $10,006,000.00
  • TMP $286,367,000.00
  • Revenue This Year
  • RLAY N/A
  • TMP N/A
  • Revenue Next Year
  • RLAY N/A
  • TMP $6.80
  • P/E Ratio
  • RLAY N/A
  • TMP $16.24
  • Revenue Growth
  • RLAY N/A
  • TMP 30.04
  • 52 Week Low
  • RLAY $5.03
  • TMP $43.09
  • 52 Week High
  • RLAY $12.14
  • TMP $78.28
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 28.59
  • TMP 65.43
  • Support Level
  • RLAY $5.96
  • TMP $73.52
  • Resistance Level
  • RLAY $6.39
  • TMP $76.68
  • Average True Range (ATR)
  • RLAY 0.36
  • TMP 2.71
  • MACD
  • RLAY -0.04
  • TMP 0.56
  • Stochastic Oscillator
  • RLAY 5.10
  • TMP 80.76

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About TMP Tompkins Financial Corporation

Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.

Share on Social Networks: